ArticleAdvances in radiation oncology

A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer.

Muhammad Hamid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.